The pathological distinction between “Deep penetrating” dermatofibroma and dermatofibrosarcoma protuberans
- 1 March 1999
- journal article
- Published by Frontline Medical Communications, Inc. in Seminars in Cutaneous Medicine and Surgery
- Vol. 18 (1) , 91-98
- https://doi.org/10.1016/s1085-5629(99)80014-5
Abstract
In selected cases, the clinicopathological distinction between deep penetrating dermatofibroma (DPDF), which involves the subcutis, and dermatofibrosarcoma protuberans (DFSPs) may be challenging. In most instances, attention to the cytological constituency of the lesions and the overall architecture is sufficient to make this separation. DPDF is typified by cellular heterogeneity, including glant cells and lipidized histiocytes; when it extends into the hypodermis, it does so either using the interlobular subcuticular fibrous septa as scaffoids or in the form of broad pushing fronts of tumor. In contrast, DFSP is a cytologically monotypical tumor, which entraps subcutaneous adipocytes diffusely or grows in stratified horizontal plates in the hypodermis. In the minority of cases where conventional morphological analysis of optimal biopsy specimens is diagnostically indeterminate, immunostaining for CD34 and factor XIIIa (FXIIIa) is helpful; it is also often necessary when a poorty-representative sample of the lesion has been obtained by the clinician. Characteristically, DF is diffusely FXIIIa-reactive and CD34-negative, whereas DFSP manifests the converse of those findings. Other markers such as Kl-M1p, mutant p53 protein, and metallothlonein may also provide adjuvant diagnostic information in this context, as may the observation of abnormalities in chromosomes 17 and 22 by direct karyotypic analysis.Keywords
This publication has 63 references indexed in Scilit:
- Immunohistochemical characterization of dermatofibrosarcoma protuberans with practical applications for diagnosis and treatmentJournal of the American Academy of Dermatology, 1997
- Prominent Myofibroblastic DifferentiationThe American Journal of Dermatopathology, 1997
- Cytogenetics and experimental models of sarcomasCurrent Opinion in Oncology, 1995
- Dermatomyofibroma: additional observations on a distinctive cutaneous myofibroblastic tumour with emphasis on differential diagnosisBritish Journal of Dermatology, 1993
- Expression of the human progenitor cell antigen CD34 (HPCA-1) distinguishes dermatofibrosarcoma protuberans from fibrous histiocytoma in formalin-fixed, paraffin-embedded tissueJournal of the American Academy of Dermatology, 1993
- DermatomyofibromaJournal of Cutaneous Pathology, 1992
- Palisading cutaneous fibrous histiocytomaJournal of Cutaneous Pathology, 1986
- Aneurysmal (angiomatoid) fibrous histiocytomaJournal of Cutaneous Pathology, 1985
- Aneurysmal (“Angiomatoid”) fibrous histiocytoma of the skinCancer, 1981
- Dimple Sign to Differentiate Benign from Malignant Pigmented Cutaneous LesionsNew England Journal of Medicine, 1977